Blood Cancer Discovery impact factor and ranking
This profile summarizes the journal metrics and publication information available in the current directory record.
Blood Cancer Discovery metric snapshot
Blood Cancer Discovery has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is AMER ASSOC CANCER RESEARCH. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 11.5. The five-year Journal Impact Factor is 11.5, giving a second citation window for comparison. The journal is recorded in quartile Q1 for its listed JCR category.
Category position and quartile
The recorded JCR category position is 25 out of 326 journals. Based on that rank position, the journal sits within approximately the top 7.7% of the listed category. Its listed quartile is Q1. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.
How the citation indicators compare
The standard and five-year Journal Impact Factors are both 11.5 in this record. Without journal self-citations, the Impact Factor is 11.3, a difference of 0.2 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 2.83. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.
Citation and publication counts
For 2025, the directory record for Blood Cancer Discovery lists total cites: 1,370; total articles: 19; citable items: 26. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.
Citation half-life profile
The cited half-life is 2.9 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 5.6 years, indicating the median age of references used by the journal’s articles.
Identifiers and verification
Blood Cancer Discovery is identified in this directory by print ISSN 2643-3230 and electronic ISSN 2643-3249. The publisher is recorded as AMER ASSOC CANCER RESEARCH. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.
Complete journal information
Use this table to verify the individual metric values, identifiers and publication details stored for this journal.
| Journal name | Blood Cancer Discovery |
|---|---|
| Abbreviated journal | BLOOD CANCER DISCOV |
| Publisher | AMER ASSOC CANCER RESEARCH |
| Metric year | 2025 |
| Overall rank | 442 |
| ISSN | 2643-3230 |
| eISSN | 2643-3249 |
| Total cites | 1,370 |
| Total articles | 19 |
| Citable items | 26 |
| Cited half-life | 2.9 years |
| Citing half-life | 5.6 years |
| JCR-based Journal Impact Factor | 11.5 |
| 5-Year Impact Factor | 11.5 |
| Impact Factor without journal self-cites | 11.3 |
| Journal Citation Indicator | 2.83 |
| JCR Impact Factor quartile | Q1 |
| JCR category rank | 25/326 |
| Database record updated |
Frequently asked questions
What is the 2025 JCR-based Journal Impact Factor of Blood Cancer Discovery?
The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Blood Cancer Discovery is 11.5 for the 2025 metric year.
What are the JCR quartile and category rank of Blood Cancer Discovery?
Blood Cancer Discovery is listed with quartile Q1 and category rank 25/326. These values are category-specific and should be verified against the official JCR record when used for formal assessment.
What is the five-year Journal Impact Factor of Blood Cancer Discovery?
The five-year Journal Impact Factor recorded for Blood Cancer Discovery is 11.5. It uses a longer citation window than the standard Journal Impact Factor.
Who publishes Blood Cancer Discovery?
Blood Cancer Discovery is listed in this directory as being published by AMER ASSOC CANCER RESEARCH.
Related journal profiles
Journals in the same approved specialty or subject are shown first, followed by same-publisher or similar-metric records when needed.